Error: Could not add to watchlist. X

ImmunoGen Inc

+ Watchlist
IMGN:US
NASDAQ GS
18.02
USD
0.12
0.67%
As of 20:10:00 ET on 08/01/2015.
Open
16.97
Day Range
16.80 - 18.78
Volume
961,998
Previous Close
17.90
52Wk Range
5.34 - 19.43
1 Yr Return
72.11%
Open
16.97
Day Range
16.80 - 18.78
Volume
961,998
Previous Close
17.90
52Wk Range
5.34 - 19.43
1 Yr Return
72.11%
YTD Return
195.41%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.70
Market Cap (b USD)
1.553
Shares Outstanding (m)
86.185
Price/Sales (TTM)
18.20
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. A TAP compound uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.
ADDRESS
830 Winter Street
Waltham, MA 02451-1477
United States
PHONE
1-781-895-0600
  • Daniel M Junius "Dan"
    President/CEO
  • David B Johnston "Dave"
    Exec VP/CFO/Treasurer
  • Sandra E Poole
    Senior VP:Technical Operations
  • Charles Q Morris "Charlie"
    Exec VP/Chief Development Officer
  • Anna Berkenblit
    VP/Chief Medical Officer
Show More